nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—ABCC1—Cyclosporine—rheumatoid arthritis	0.0682	0.654	CbGbCtD
Epirubicin—ABCC1—Methotrexate—rheumatoid arthritis	0.0361	0.346	CbGbCtD
Epirubicin—CHD1—parotid gland—rheumatoid arthritis	0.00761	0.0833	CbGeAlD
Epirubicin—CHD1—saliva-secreting gland—rheumatoid arthritis	0.00729	0.0798	CbGeAlD
Epirubicin—DHCR7—parotid gland—rheumatoid arthritis	0.00513	0.0562	CbGeAlD
Epirubicin—DHCR7—saliva-secreting gland—rheumatoid arthritis	0.00492	0.0538	CbGeAlD
Epirubicin—CHD1—lymphoid tissue—rheumatoid arthritis	0.0049	0.0536	CbGeAlD
Epirubicin—YWHAG—parotid gland—rheumatoid arthritis	0.00471	0.0516	CbGeAlD
Epirubicin—CHD1—tendon—rheumatoid arthritis	0.00461	0.0504	CbGeAlD
Epirubicin—YWHAG—saliva-secreting gland—rheumatoid arthritis	0.00451	0.0494	CbGeAlD
Epirubicin—YWHAG—connective tissue—rheumatoid arthritis	0.00415	0.0454	CbGeAlD
Epirubicin—AURKA—lymphoid tissue—rheumatoid arthritis	0.00395	0.0432	CbGeAlD
Epirubicin—AURKA—digestive system—rheumatoid arthritis	0.0039	0.0427	CbGeAlD
Epirubicin—AURKA—tendon—rheumatoid arthritis	0.00371	0.0406	CbGeAlD
Epirubicin—AURKA—Calcipotriol—Ergocalciferol—rheumatoid arthritis	0.00348	0.346	CbGdCrCtD
Epirubicin—PLA2G4A—saliva-secreting gland—rheumatoid arthritis	0.00337	0.0368	CbGeAlD
Epirubicin—DHCR7—lymphoid tissue—rheumatoid arthritis	0.0033	0.0362	CbGeAlD
Epirubicin—DHCR7—digestive system—rheumatoid arthritis	0.00326	0.0357	CbGeAlD
Epirubicin—PLA2G4A—connective tissue—rheumatoid arthritis	0.00309	0.0338	CbGeAlD
Epirubicin—YWHAG—lymphoid tissue—rheumatoid arthritis	0.00303	0.0332	CbGeAlD
Epirubicin—YWHAG—digestive system—rheumatoid arthritis	0.00299	0.0328	CbGeAlD
Epirubicin—PLA2G4A—Raltitrexed—Methotrexate—rheumatoid arthritis	0.00285	0.283	CbGdCrCtD
Epirubicin—YWHAG—tendon—rheumatoid arthritis	0.00285	0.0312	CbGeAlD
Epirubicin—UGT2B7—digestive system—rheumatoid arthritis	0.0027	0.0296	CbGeAlD
Epirubicin—Doxorubicin—NOS3—rheumatoid arthritis	0.00265	0.509	CrCbGaD
Epirubicin—Doxorubicin—NOS2—rheumatoid arthritis	0.00256	0.491	CrCbGaD
Epirubicin—PLA2G4A—tendon—rheumatoid arthritis	0.00213	0.0233	CbGeAlD
Epirubicin—TOP2A—tendon—rheumatoid arthritis	0.00202	0.0221	CbGeAlD
Epirubicin—ABCC1—parotid gland—rheumatoid arthritis	0.00201	0.022	CbGeAlD
Epirubicin—ABCC1—tendon—rheumatoid arthritis	0.00122	0.0133	CbGeAlD
Epirubicin—PLA2G4A—Dexamethasone—Hydrocortisone—rheumatoid arthritis	0.000264	0.0262	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Hydrocortisone—rheumatoid arthritis	0.000264	0.0262	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Methylprednisolone—rheumatoid arthritis	0.000249	0.0247	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Methylprednisolone—rheumatoid arthritis	0.000249	0.0247	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Dexamethasone—rheumatoid arthritis	0.000245	0.0244	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Betamethasone—rheumatoid arthritis	0.000245	0.0244	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Triamcinolone—rheumatoid arthritis	0.000239	0.0238	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Triamcinolone—rheumatoid arthritis	0.000239	0.0238	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Prednisone—rheumatoid arthritis	0.000227	0.0226	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Prednisone—rheumatoid arthritis	0.000227	0.0226	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Prednisolone—rheumatoid arthritis	0.000222	0.022	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Prednisolone—rheumatoid arthritis	0.000222	0.022	CbGdCrCtD
Epirubicin—TOP2A—Methyltestosterone—Hydrocortisone—rheumatoid arthritis	0.000216	0.0215	CbGdCrCtD
Epirubicin—TOP2A—Methyltestosterone—Prednisone—rheumatoid arthritis	0.000186	0.0185	CbGdCrCtD
Epirubicin—TOP2A—Methyltestosterone—Prednisolone—rheumatoid arthritis	0.000182	0.0181	CbGdCrCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	0.000152	0.000617	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—TNF—rheumatoid arthritis	0.000152	0.000616	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—TNF—rheumatoid arthritis	0.000151	0.000613	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—SH2B3—rheumatoid arthritis	0.000151	0.000612	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PDE2A—rheumatoid arthritis	0.000151	0.000612	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—BIRC5—rheumatoid arthritis	0.000148	0.000604	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—rheumatoid arthritis	0.000148	0.000603	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—FADS2—rheumatoid arthritis	0.000148	0.000601	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	0.000142	0.000577	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—FN1—rheumatoid arthritis	0.000141	0.000573	CbGpPWpGaD
Epirubicin—TOP2A—Norethindrone—Hydrocortisone—rheumatoid arthritis	0.000141	0.014	CbGdCrCtD
Epirubicin—TOP2A—Cell Cycle—CDK6—rheumatoid arthritis	0.00014	0.000567	CbGpPWpGaD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—MAPK8—rheumatoid arthritis	0.000138	0.000561	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—UBE2D1—rheumatoid arthritis	0.000137	0.000558	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—GATA3—rheumatoid arthritis	0.000135	0.000549	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—TP53—rheumatoid arthritis	0.000134	0.000543	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—rheumatoid arthritis	0.000133	0.00054	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—BIRC5—rheumatoid arthritis	0.000133	0.00054	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TIMP1—rheumatoid arthritis	0.000128	0.000521	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SYVN1—rheumatoid arthritis	0.000128	0.000519	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PLD4—rheumatoid arthritis	0.000126	0.000512	CbGpPWpGaD
Epirubicin—Pharyngitis—Methotrexate—rheumatoid arthritis	0.000126	0.000231	CcSEcCtD
Epirubicin—Nausea—Leflunomide—rheumatoid arthritis	0.000125	0.000231	CcSEcCtD
Epirubicin—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000125	0.00023	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000125	0.00023	CcSEcCtD
Epirubicin—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000125	0.00023	CcSEcCtD
Epirubicin—Vision blurred—Prednisone—rheumatoid arthritis	0.000124	0.000229	CcSEcCtD
Epirubicin—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000124	0.000229	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000124	0.000229	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000124	0.000228	CcSEcCtD
Epirubicin—Pain—Hydrocortisone—rheumatoid arthritis	0.000124	0.000228	CcSEcCtD
Epirubicin—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.000124	0.000228	CcSEcCtD
Epirubicin—Oedema—Dexamethasone—rheumatoid arthritis	0.000124	0.000228	CcSEcCtD
Epirubicin—Oedema—Betamethasone—rheumatoid arthritis	0.000124	0.000228	CcSEcCtD
Epirubicin—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.000124	0.000228	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—PLD4—rheumatoid arthritis	0.000124	0.000502	CbGpPWpGaD
Epirubicin—Insomnia—Triamcinolone—rheumatoid arthritis	0.000123	0.000227	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	0.000123	0.0005	CbGpPWpGaD
Epirubicin—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000123	0.000226	CcSEcCtD
Epirubicin—Infection—Betamethasone—rheumatoid arthritis	0.000123	0.000226	CcSEcCtD
Epirubicin—Infection—Dexamethasone—rheumatoid arthritis	0.000123	0.000226	CcSEcCtD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL6—rheumatoid arthritis	0.000122	0.000497	CbGpPWpGaD
Epirubicin—Ill-defined disorder—Prednisone—rheumatoid arthritis	0.000122	0.000225	CcSEcCtD
Epirubicin—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000122	0.000225	CcSEcCtD
Epirubicin—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000122	0.000225	CcSEcCtD
Epirubicin—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000122	0.000225	CcSEcCtD
Epirubicin—Visual impairment—Methotrexate—rheumatoid arthritis	0.000122	0.000225	CcSEcCtD
Epirubicin—Anaemia—Prednisone—rheumatoid arthritis	0.000122	0.000224	CcSEcCtD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL6—rheumatoid arthritis	0.000122	0.000495	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ACAN—rheumatoid arthritis	0.000122	0.000495	CbGpPWpGaD
Epirubicin—Shock—Dexamethasone—rheumatoid arthritis	0.000122	0.000224	CcSEcCtD
Epirubicin—Shock—Betamethasone—rheumatoid arthritis	0.000122	0.000224	CcSEcCtD
Epirubicin—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000121	0.000224	CcSEcCtD
Epirubicin—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000121	0.000223	CcSEcCtD
Epirubicin—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000121	0.000223	CcSEcCtD
Epirubicin—Agitation—Prednisone—rheumatoid arthritis	0.000121	0.000223	CcSEcCtD
Epirubicin—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.000121	0.000223	CcSEcCtD
Epirubicin—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.000121	0.000223	CcSEcCtD
Epirubicin—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000121	0.000222	CcSEcCtD
Epirubicin—Tachycardia—Betamethasone—rheumatoid arthritis	0.000121	0.000222	CcSEcCtD
Epirubicin—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.00012	0.000221	CcSEcCtD
Epirubicin—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.00012	0.000221	CcSEcCtD
Epirubicin—Erythema multiforme—Methotrexate—rheumatoid arthritis	0.00012	0.00022	CcSEcCtD
Epirubicin—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.00012	0.00022	CcSEcCtD
Epirubicin—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.000119	0.00022	CcSEcCtD
Epirubicin—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.000119	0.00022	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—ACAN—rheumatoid arthritis	0.000119	0.000485	CbGpPWpGaD
Epirubicin—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000119	0.00022	CcSEcCtD
Epirubicin—Malaise—Prednisone—rheumatoid arthritis	0.000119	0.000219	CcSEcCtD
Epirubicin—DHCR7—Metabolism—CAT—rheumatoid arthritis	0.000119	0.000483	CbGpPWpGaD
Epirubicin—Vertigo—Prednisone—rheumatoid arthritis	0.000118	0.000218	CcSEcCtD
Epirubicin—Eye disorder—Methotrexate—rheumatoid arthritis	0.000118	0.000218	CcSEcCtD
Epirubicin—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000118	0.000218	CcSEcCtD
Epirubicin—Syncope—Prednisone—rheumatoid arthritis	0.000118	0.000218	CcSEcCtD
Epirubicin—Tinnitus—Methotrexate—rheumatoid arthritis	0.000118	0.000217	CcSEcCtD
Epirubicin—Anorexia—Dexamethasone—rheumatoid arthritis	0.000118	0.000217	CcSEcCtD
Epirubicin—Anorexia—Betamethasone—rheumatoid arthritis	0.000118	0.000217	CcSEcCtD
Epirubicin—Urticaria—Prednisolone—rheumatoid arthritis	0.000118	0.000217	CcSEcCtD
Epirubicin—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000118	0.000216	CcSEcCtD
Epirubicin—Fatigue—Triamcinolone—rheumatoid arthritis	0.000117	0.000216	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL6—rheumatoid arthritis	0.000117	0.000477	CbGpPWpGaD
Epirubicin—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000117	0.000216	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—ALB—rheumatoid arthritis	0.000117	0.000476	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL13—rheumatoid arthritis	0.000117	0.000476	CbGpPWpGaD
Epirubicin—Asthenia—Cyclosporine—rheumatoid arthritis	0.000117	0.000215	CcSEcCtD
Epirubicin—Pain—Triamcinolone—rheumatoid arthritis	0.000116	0.000215	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	0.000116	0.000471	CbGpPWpGaD
Epirubicin—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000116	0.000213	CcSEcCtD
Epirubicin—Hypotension—Dexamethasone—rheumatoid arthritis	0.000115	0.000213	CcSEcCtD
Epirubicin—Hypotension—Betamethasone—rheumatoid arthritis	0.000115	0.000213	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	0.000115	0.000469	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—RASGRP1—rheumatoid arthritis	0.000115	0.000469	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—rheumatoid arthritis	0.000115	0.000468	CbGpPWpGaD
Epirubicin—Pruritus—Cyclosporine—rheumatoid arthritis	0.000115	0.000212	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—SYK—rheumatoid arthritis	0.000115	0.000467	CbGpPWpGaD
Epirubicin—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000115	0.000212	CcSEcCtD
Epirubicin—Angiopathy—Methotrexate—rheumatoid arthritis	0.000115	0.000212	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—SLC25A12—rheumatoid arthritis	0.000114	0.000465	CbGpPWpGaD
Epirubicin—Immune system disorder—Methotrexate—rheumatoid arthritis	0.000114	0.000211	CcSEcCtD
Epirubicin—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000114	0.000211	CcSEcCtD
Epirubicin—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000114	0.000211	CcSEcCtD
Epirubicin—Convulsion—Prednisone—rheumatoid arthritis	0.000114	0.00021	CcSEcCtD
Epirubicin—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000114	0.00021	CcSEcCtD
Epirubicin—ABCC1—Disease—ACAN—rheumatoid arthritis	0.000114	0.000463	CbGpPWpGaD
Epirubicin—Hypertension—Prednisone—rheumatoid arthritis	0.000114	0.00021	CcSEcCtD
Epirubicin—Chills—Methotrexate—rheumatoid arthritis	0.000114	0.000209	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	0.000113	0.000461	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PRKCQ—rheumatoid arthritis	0.000113	0.000459	CbGpPWpGaD
Epirubicin—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000113	0.000207	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000113	0.000207	CcSEcCtD
Epirubicin—Arthralgia—Prednisone—rheumatoid arthritis	0.000112	0.000207	CcSEcCtD
Epirubicin—Myalgia—Prednisone—rheumatoid arthritis	0.000112	0.000207	CcSEcCtD
Epirubicin—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000112	0.000207	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—SLC25A12—rheumatoid arthritis	0.000112	0.000456	CbGpPWpGaD
Epirubicin—TOP2A—Levonorgestrel—Hydrocortisone—rheumatoid arthritis	0.000112	0.0111	CbGdCrCtD
Epirubicin—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000112	0.000206	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—CCL21—rheumatoid arthritis	0.000112	0.000455	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SYVN1—rheumatoid arthritis	0.000112	0.000455	CbGpPWpGaD
Epirubicin—Anxiety—Prednisone—rheumatoid arthritis	0.000112	0.000206	CcSEcCtD
Epirubicin—Alopecia—Methotrexate—rheumatoid arthritis	0.000112	0.000206	CcSEcCtD
Epirubicin—Insomnia—Betamethasone—rheumatoid arthritis	0.000112	0.000206	CcSEcCtD
Epirubicin—Insomnia—Dexamethasone—rheumatoid arthritis	0.000112	0.000206	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000112	0.000205	CcSEcCtD
Epirubicin—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000111	0.000205	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—PTGES—rheumatoid arthritis	0.000111	0.000452	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GC—rheumatoid arthritis	0.000111	0.000452	CbGpPWpGaD
Epirubicin—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000111	0.000205	CcSEcCtD
Epirubicin—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000111	0.000204	CcSEcCtD
Epirubicin—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000111	0.000204	CcSEcCtD
Epirubicin—Discomfort—Prednisone—rheumatoid arthritis	0.000111	0.000204	CcSEcCtD
Epirubicin—Mental disorder—Methotrexate—rheumatoid arthritis	0.000111	0.000204	CcSEcCtD
Epirubicin—Erythema—Methotrexate—rheumatoid arthritis	0.00011	0.000203	CcSEcCtD
Epirubicin—Malnutrition—Methotrexate—rheumatoid arthritis	0.00011	0.000203	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—PTGES—rheumatoid arthritis	0.000109	0.000444	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GC—rheumatoid arthritis	0.000109	0.000444	CbGpPWpGaD
Epirubicin—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000109	0.000201	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—MAPK8—rheumatoid arthritis	0.000109	0.000443	CbGpPWpGaD
Epirubicin—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000109	0.0002	CcSEcCtD
Epirubicin—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000109	0.0002	CcSEcCtD
Epirubicin—Urticaria—Triamcinolone—rheumatoid arthritis	0.000108	0.000199	CcSEcCtD
Epirubicin—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000108	0.000199	CcSEcCtD
Epirubicin—Dysgeusia—Methotrexate—rheumatoid arthritis	0.000108	0.000199	CcSEcCtD
Epirubicin—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000108	0.000198	CcSEcCtD
Epirubicin—Dizziness—Cyclosporine—rheumatoid arthritis	0.000108	0.000198	CcSEcCtD
Epirubicin—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.000108	0.000198	CcSEcCtD
Epirubicin—Oedema—Prednisone—rheumatoid arthritis	0.000108	0.000198	CcSEcCtD
Epirubicin—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000107	0.000198	CcSEcCtD
Epirubicin—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000107	0.000198	CcSEcCtD
Epirubicin—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000107	0.000198	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—TAGAP—rheumatoid arthritis	0.000107	0.000436	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SLC25A12—rheumatoid arthritis	0.000107	0.000435	CbGpPWpGaD
Epirubicin—Infection—Prednisone—rheumatoid arthritis	0.000107	0.000197	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000107	0.000196	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000107	0.000196	CcSEcCtD
Epirubicin—Back pain—Methotrexate—rheumatoid arthritis	0.000107	0.000196	CcSEcCtD
Epirubicin—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000107	0.000196	CcSEcCtD
Epirubicin—Fatigue—Betamethasone—rheumatoid arthritis	0.000107	0.000196	CcSEcCtD
Epirubicin—Fatigue—Dexamethasone—rheumatoid arthritis	0.000107	0.000196	CcSEcCtD
Epirubicin—Shock—Prednisone—rheumatoid arthritis	0.000106	0.000195	CcSEcCtD
Epirubicin—Pain—Dexamethasone—rheumatoid arthritis	0.000106	0.000195	CcSEcCtD
Epirubicin—Pain—Betamethasone—rheumatoid arthritis	0.000106	0.000195	CcSEcCtD
Epirubicin—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000106	0.000194	CcSEcCtD
Epirubicin—UGT2B7—NRF2 pathway—TGFB1—rheumatoid arthritis	0.000105	0.000428	CbGpPWpGaD
Epirubicin—Tachycardia—Prednisone—rheumatoid arthritis	0.000105	0.000193	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	0.000105	0.000426	CbGpPWpGaD
Epirubicin—Skin disorder—Prednisone—rheumatoid arthritis	0.000105	0.000193	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CX3CR1—rheumatoid arthritis	0.000104	0.000424	CbGpPWpGaD
Epirubicin—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.000104	0.000192	CcSEcCtD
Epirubicin—Vision blurred—Methotrexate—rheumatoid arthritis	0.000104	0.000191	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle, Mitotic—BIRC5—rheumatoid arthritis	0.000104	0.000422	CbGpPWpGaD
Epirubicin—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000104	0.000191	CcSEcCtD
Epirubicin—Vomiting—Cyclosporine—rheumatoid arthritis	0.000103	0.000191	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—PLB1—rheumatoid arthritis	0.000103	0.000421	CbGpPWpGaD
Epirubicin—Rash—Cyclosporine—rheumatoid arthritis	0.000103	0.000189	CcSEcCtD
Epirubicin—Anorexia—Prednisone—rheumatoid arthritis	0.000103	0.000189	CcSEcCtD
Epirubicin—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000103	0.000189	CcSEcCtD
Epirubicin—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000102	0.000188	CcSEcCtD
Epirubicin—Ill-defined disorder—Methotrexate—rheumatoid arthritis	0.000102	0.000188	CcSEcCtD
Epirubicin—Headache—Cyclosporine—rheumatoid arthritis	0.000102	0.000188	CcSEcCtD
Epirubicin—Anaemia—Methotrexate—rheumatoid arthritis	0.000102	0.000188	CcSEcCtD
Epirubicin—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000102	0.000188	CcSEcCtD
Epirubicin—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000102	0.000188	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—PLB1—rheumatoid arthritis	0.000101	0.000412	CbGpPWpGaD
Epirubicin—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000101	0.000186	CcSEcCtD
Epirubicin—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000101	0.000186	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2RB—rheumatoid arthritis	0.0001	0.000408	CbGpPWpGaD
Epirubicin—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.0001	0.000185	CcSEcCtD
Epirubicin—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.0001	0.000184	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	9.99e-05	0.000406	CbGpPWpGaD
Epirubicin—Malaise—Methotrexate—rheumatoid arthritis	9.94e-05	0.000183	CcSEcCtD
Epirubicin—DHCR7—Metabolism—MTHFR—rheumatoid arthritis	9.92e-05	0.000403	CbGpPWpGaD
Epirubicin—Vertigo—Methotrexate—rheumatoid arthritis	9.9e-05	0.000182	CcSEcCtD
Epirubicin—Diarrhoea—Hydrocortisone—rheumatoid arthritis	9.9e-05	0.000182	CcSEcCtD
Epirubicin—ABCC1—Metabolism—PLD4—rheumatoid arthritis	9.87e-05	0.000401	CbGpPWpGaD
Epirubicin—Leukopenia—Methotrexate—rheumatoid arthritis	9.87e-05	0.000182	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	9.82e-05	0.000399	CbGpPWpGaD
Epirubicin—Urticaria—Betamethasone—rheumatoid arthritis	9.82e-05	0.000181	CcSEcCtD
Epirubicin—Urticaria—Dexamethasone—rheumatoid arthritis	9.82e-05	0.000181	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	9.81e-05	0.000181	CcSEcCtD
Epirubicin—Dizziness—Prednisolone—rheumatoid arthritis	9.79e-05	0.00018	CcSEcCtD
Epirubicin—Asthenia—Triamcinolone—rheumatoid arthritis	9.77e-05	0.00018	CcSEcCtD
Epirubicin—Body temperature increased—Betamethasone—rheumatoid arthritis	9.77e-05	0.00018	CcSEcCtD
Epirubicin—Abdominal pain—Dexamethasone—rheumatoid arthritis	9.77e-05	0.00018	CcSEcCtD
Epirubicin—Body temperature increased—Dexamethasone—rheumatoid arthritis	9.77e-05	0.00018	CcSEcCtD
Epirubicin—Abdominal pain—Betamethasone—rheumatoid arthritis	9.77e-05	0.00018	CcSEcCtD
Epirubicin—Asthenia—Methylprednisolone—rheumatoid arthritis	9.75e-05	0.00018	CcSEcCtD
Epirubicin—Insomnia—Prednisone—rheumatoid arthritis	9.73e-05	0.000179	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—C5—rheumatoid arthritis	9.7e-05	0.000394	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PLB1—rheumatoid arthritis	9.68e-05	0.000394	CbGpPWpGaD
Epirubicin—Nausea—Cyclosporine—rheumatoid arthritis	9.67e-05	0.000178	CcSEcCtD
Epirubicin—Paraesthesia—Prednisone—rheumatoid arthritis	9.66e-05	0.000178	CcSEcCtD
Epirubicin—Pruritus—Triamcinolone—rheumatoid arthritis	9.64e-05	0.000177	CcSEcCtD
Epirubicin—Cough—Methotrexate—rheumatoid arthritis	9.62e-05	0.000177	CcSEcCtD
Epirubicin—Pruritus—Methylprednisolone—rheumatoid arthritis	9.62e-05	0.000177	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	9.61e-05	0.000391	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PTK2—rheumatoid arthritis	9.59e-05	0.00039	CbGpPWpGaD
Epirubicin—Dizziness—Hydrocortisone—rheumatoid arthritis	9.57e-05	0.000176	CcSEcCtD
Epirubicin—Convulsion—Methotrexate—rheumatoid arthritis	9.55e-05	0.000176	CcSEcCtD
Epirubicin—ABCC1—Metabolism—ACAN—rheumatoid arthritis	9.54e-05	0.000388	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IL2—rheumatoid arthritis	9.5e-05	0.000386	CbGpPWpGaD
Epirubicin—Dyspepsia—Prednisone—rheumatoid arthritis	9.47e-05	0.000174	CcSEcCtD
Epirubicin—Chest pain—Methotrexate—rheumatoid arthritis	9.38e-05	0.000173	CcSEcCtD
Epirubicin—Myalgia—Methotrexate—rheumatoid arthritis	9.38e-05	0.000173	CcSEcCtD
Epirubicin—Arthralgia—Methotrexate—rheumatoid arthritis	9.38e-05	0.000173	CcSEcCtD
Epirubicin—Decreased appetite—Prednisone—rheumatoid arthritis	9.36e-05	0.000172	CcSEcCtD
Epirubicin—Rash—Prednisolone—rheumatoid arthritis	9.34e-05	0.000172	CcSEcCtD
Epirubicin—Dermatitis—Prednisolone—rheumatoid arthritis	9.33e-05	0.000172	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	9.32e-05	0.000172	CcSEcCtD
Epirubicin—Diarrhoea—Methylprednisolone—rheumatoid arthritis	9.3e-05	0.000171	CcSEcCtD
Epirubicin—TOP2A—Cell Cycle—BIRC5—rheumatoid arthritis	9.29e-05	0.000377	CbGpPWpGaD
Epirubicin—Fatigue—Prednisone—rheumatoid arthritis	9.28e-05	0.000171	CcSEcCtD
Epirubicin—Headache—Prednisolone—rheumatoid arthritis	9.28e-05	0.000171	CcSEcCtD
Epirubicin—Discomfort—Methotrexate—rheumatoid arthritis	9.27e-05	0.000171	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—CSF2—rheumatoid arthritis	9.26e-05	0.000377	CbGpPWpGaD
Epirubicin—Constipation—Prednisone—rheumatoid arthritis	9.2e-05	0.00017	CcSEcCtD
Epirubicin—Vomiting—Hydrocortisone—rheumatoid arthritis	9.2e-05	0.000169	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CCR6—rheumatoid arthritis	9.12e-05	0.000371	CbGpPWpGaD
Epirubicin—Rash—Hydrocortisone—rheumatoid arthritis	9.12e-05	0.000168	CcSEcCtD
Epirubicin—Dermatitis—Hydrocortisone—rheumatoid arthritis	9.11e-05	0.000168	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—MED1—rheumatoid arthritis	9.07e-05	0.000369	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	9.07e-05	0.000369	CbGpPWpGaD
Epirubicin—Confusional state—Methotrexate—rheumatoid arthritis	9.07e-05	0.000167	CcSEcCtD
Epirubicin—Headache—Hydrocortisone—rheumatoid arthritis	9.06e-05	0.000167	CcSEcCtD
Epirubicin—Dizziness—Triamcinolone—rheumatoid arthritis	9.01e-05	0.000166	CcSEcCtD
Epirubicin—Anaphylactic shock—Methotrexate—rheumatoid arthritis	9e-05	0.000166	CcSEcCtD
Epirubicin—Dizziness—Methylprednisolone—rheumatoid arthritis	8.99e-05	0.000166	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	8.97e-05	0.000365	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SLC25A12—rheumatoid arthritis	8.97e-05	0.000364	CbGpPWpGaD
Epirubicin—Infection—Methotrexate—rheumatoid arthritis	8.94e-05	0.000165	CcSEcCtD
Epirubicin—ABCC1—Disease—RBPJ—rheumatoid arthritis	8.94e-05	0.000363	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—MED1—rheumatoid arthritis	8.9e-05	0.000362	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PDE2A—rheumatoid arthritis	8.9e-05	0.000362	CbGpPWpGaD
Epirubicin—Feeling abnormal—Prednisone—rheumatoid arthritis	8.87e-05	0.000163	CcSEcCtD
Epirubicin—Asthenia—Dexamethasone—rheumatoid arthritis	8.87e-05	0.000163	CcSEcCtD
Epirubicin—Asthenia—Betamethasone—rheumatoid arthritis	8.87e-05	0.000163	CcSEcCtD
Epirubicin—Nervous system disorder—Methotrexate—rheumatoid arthritis	8.82e-05	0.000162	CcSEcCtD
Epirubicin—Thrombocytopenia—Methotrexate—rheumatoid arthritis	8.81e-05	0.000162	CcSEcCtD
Epirubicin—Gastrointestinal pain—Prednisone—rheumatoid arthritis	8.8e-05	0.000162	CcSEcCtD
Epirubicin—Nausea—Prednisolone—rheumatoid arthritis	8.8e-05	0.000162	CcSEcCtD
Epirubicin—Pruritus—Betamethasone—rheumatoid arthritis	8.74e-05	0.000161	CcSEcCtD
Epirubicin—Pruritus—Dexamethasone—rheumatoid arthritis	8.74e-05	0.000161	CcSEcCtD
Epirubicin—Skin disorder—Methotrexate—rheumatoid arthritis	8.74e-05	0.000161	CcSEcCtD
Epirubicin—ABCC1—Metabolism—GC—rheumatoid arthritis	8.72e-05	0.000354	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGES—rheumatoid arthritis	8.72e-05	0.000354	CbGpPWpGaD
Epirubicin—Hyperhidrosis—Methotrexate—rheumatoid arthritis	8.7e-05	0.00016	CcSEcCtD
Epirubicin—Vomiting—Triamcinolone—rheumatoid arthritis	8.66e-05	0.000159	CcSEcCtD
Epirubicin—Vomiting—Methylprednisolone—rheumatoid arthritis	8.64e-05	0.000159	CcSEcCtD
Epirubicin—Nausea—Hydrocortisone—rheumatoid arthritis	8.59e-05	0.000158	CcSEcCtD
Epirubicin—Rash—Triamcinolone—rheumatoid arthritis	8.59e-05	0.000158	CcSEcCtD
Epirubicin—Dermatitis—Triamcinolone—rheumatoid arthritis	8.58e-05	0.000158	CcSEcCtD
Epirubicin—Anorexia—Methotrexate—rheumatoid arthritis	8.57e-05	0.000158	CcSEcCtD
Epirubicin—Rash—Methylprednisolone—rheumatoid arthritis	8.57e-05	0.000158	CcSEcCtD
Epirubicin—Dermatitis—Methylprednisolone—rheumatoid arthritis	8.56e-05	0.000158	CcSEcCtD
Epirubicin—Urticaria—Prednisone—rheumatoid arthritis	8.55e-05	0.000157	CcSEcCtD
Epirubicin—Headache—Triamcinolone—rheumatoid arthritis	8.53e-05	0.000157	CcSEcCtD
Epirubicin—Headache—Methylprednisolone—rheumatoid arthritis	8.51e-05	0.000157	CcSEcCtD
Epirubicin—Body temperature increased—Prednisone—rheumatoid arthritis	8.51e-05	0.000157	CcSEcCtD
Epirubicin—Abdominal pain—Prednisone—rheumatoid arthritis	8.51e-05	0.000157	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—PLB1—rheumatoid arthritis	8.49e-05	0.000345	CbGpPWpGaD
Epirubicin—Diarrhoea—Dexamethasone—rheumatoid arthritis	8.46e-05	0.000156	CcSEcCtD
Epirubicin—Diarrhoea—Betamethasone—rheumatoid arthritis	8.46e-05	0.000156	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—B3GNT2—rheumatoid arthritis	8.44e-05	0.000343	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ACP5—rheumatoid arthritis	8.44e-05	0.000343	CbGpPWpGaD
Epirubicin—Hypotension—Methotrexate—rheumatoid arthritis	8.41e-05	0.000155	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—IL2RA—rheumatoid arthritis	8.35e-05	0.000339	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL3—rheumatoid arthritis	8.34e-05	0.000339	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL2—rheumatoid arthritis	8.34e-05	0.000339	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	8.33e-05	0.000338	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ACP5—rheumatoid arthritis	8.27e-05	0.000336	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—B3GNT2—rheumatoid arthritis	8.27e-05	0.000336	CbGpPWpGaD
Epirubicin—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	8.2e-05	0.000151	CcSEcCtD
Epirubicin—Dizziness—Dexamethasone—rheumatoid arthritis	8.17e-05	0.000151	CcSEcCtD
Epirubicin—Dizziness—Betamethasone—rheumatoid arthritis	8.17e-05	0.000151	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—SAA1—rheumatoid arthritis	8.16e-05	0.000332	CbGpPWpGaD
Epirubicin—Insomnia—Methotrexate—rheumatoid arthritis	8.14e-05	0.00015	CcSEcCtD
Epirubicin—ABCC1—Metabolism—PLB1—rheumatoid arthritis	8.11e-05	0.00033	CbGpPWpGaD
Epirubicin—Nausea—Triamcinolone—rheumatoid arthritis	8.09e-05	0.000149	CcSEcCtD
Epirubicin—Paraesthesia—Methotrexate—rheumatoid arthritis	8.08e-05	0.000149	CcSEcCtD
Epirubicin—Nausea—Methylprednisolone—rheumatoid arthritis	8.07e-05	0.000149	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—rheumatoid arthritis	8.07e-05	0.000328	CbGpPWpGaD
Epirubicin—Dyspnoea—Methotrexate—rheumatoid arthritis	8.02e-05	0.000148	CcSEcCtD
Epirubicin—Somnolence—Methotrexate—rheumatoid arthritis	8e-05	0.000147	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—MMP1—rheumatoid arthritis	7.97e-05	0.000324	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—POMC—rheumatoid arthritis	7.93e-05	0.000322	CbGpPWpGaD
Epirubicin—Hypersensitivity—Prednisone—rheumatoid arthritis	7.93e-05	0.000146	CcSEcCtD
Epirubicin—Dyspepsia—Methotrexate—rheumatoid arthritis	7.92e-05	0.000146	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	7.91e-05	0.000322	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ACP5—rheumatoid arthritis	7.89e-05	0.000321	CbGpPWpGaD
Epirubicin—ABCC1—Disease—B3GNT2—rheumatoid arthritis	7.89e-05	0.000321	CbGpPWpGaD
Epirubicin—Vomiting—Dexamethasone—rheumatoid arthritis	7.86e-05	0.000145	CcSEcCtD
Epirubicin—Vomiting—Betamethasone—rheumatoid arthritis	7.86e-05	0.000145	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—RBPJ—rheumatoid arthritis	7.83e-05	0.000318	CbGpPWpGaD
Epirubicin—Decreased appetite—Methotrexate—rheumatoid arthritis	7.82e-05	0.000144	CcSEcCtD
Epirubicin—Rash—Dexamethasone—rheumatoid arthritis	7.79e-05	0.000144	CcSEcCtD
Epirubicin—Rash—Betamethasone—rheumatoid arthritis	7.79e-05	0.000144	CcSEcCtD
Epirubicin—Dermatitis—Dexamethasone—rheumatoid arthritis	7.79e-05	0.000143	CcSEcCtD
Epirubicin—Dermatitis—Betamethasone—rheumatoid arthritis	7.79e-05	0.000143	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	7.77e-05	0.000316	CbGpPWpGaD
Epirubicin—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	7.77e-05	0.000143	CcSEcCtD
Epirubicin—Fatigue—Methotrexate—rheumatoid arthritis	7.76e-05	0.000143	CcSEcCtD
Epirubicin—Headache—Dexamethasone—rheumatoid arthritis	7.74e-05	0.000143	CcSEcCtD
Epirubicin—Headache—Betamethasone—rheumatoid arthritis	7.74e-05	0.000143	CcSEcCtD
Epirubicin—Asthenia—Prednisone—rheumatoid arthritis	7.72e-05	0.000142	CcSEcCtD
Epirubicin—Pain—Methotrexate—rheumatoid arthritis	7.69e-05	0.000142	CcSEcCtD
Epirubicin—Pruritus—Prednisone—rheumatoid arthritis	7.61e-05	0.00014	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—BGN—rheumatoid arthritis	7.6e-05	0.000309	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—TP53—rheumatoid arthritis	7.6e-05	0.000309	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—BGN—rheumatoid arthritis	7.45e-05	0.000303	CbGpPWpGaD
Epirubicin—Feeling abnormal—Methotrexate—rheumatoid arthritis	7.41e-05	0.000137	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—rheumatoid arthritis	7.41e-05	0.000301	CbGpPWpGaD
Epirubicin—Diarrhoea—Prednisone—rheumatoid arthritis	7.36e-05	0.000136	CcSEcCtD
Epirubicin—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	7.36e-05	0.000135	CcSEcCtD
Epirubicin—Nausea—Dexamethasone—rheumatoid arthritis	7.34e-05	0.000135	CcSEcCtD
Epirubicin—Nausea—Betamethasone—rheumatoid arthritis	7.34e-05	0.000135	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—FN1—rheumatoid arthritis	7.27e-05	0.000295	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—ALB—rheumatoid arthritis	7.23e-05	0.000294	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—NOS2—rheumatoid arthritis	7.18e-05	0.000292	CbGpPWpGaD
Epirubicin—Urticaria—Methotrexate—rheumatoid arthritis	7.15e-05	0.000132	CcSEcCtD
Epirubicin—Dizziness—Prednisone—rheumatoid arthritis	7.12e-05	0.000131	CcSEcCtD
Epirubicin—Abdominal pain—Methotrexate—rheumatoid arthritis	7.11e-05	0.000131	CcSEcCtD
Epirubicin—Body temperature increased—Methotrexate—rheumatoid arthritis	7.11e-05	0.000131	CcSEcCtD
Epirubicin—ABCC1—Metabolism—MED1—rheumatoid arthritis	7.11e-05	0.000289	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TLE3—rheumatoid arthritis	7.11e-05	0.000289	CbGpPWpGaD
Epirubicin—ABCC1—Disease—BGN—rheumatoid arthritis	7.11e-05	0.000289	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—BDKRB2—rheumatoid arthritis	7.1e-05	0.000288	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL12—rheumatoid arthritis	7.1e-05	0.000288	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—ADRBK1—rheumatoid arthritis	7.02e-05	0.000285	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALOX5—rheumatoid arthritis	6.99e-05	0.000284	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—IL6—rheumatoid arthritis	6.95e-05	0.000283	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL13—rheumatoid arthritis	6.92e-05	0.000281	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—NOS3—rheumatoid arthritis	6.92e-05	0.000281	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALOX5—rheumatoid arthritis	6.86e-05	0.000279	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	6.85e-05	0.000279	CbGpPWpGaD
Epirubicin—Vomiting—Prednisone—rheumatoid arthritis	6.84e-05	0.000126	CcSEcCtD
Epirubicin—Rash—Prednisone—rheumatoid arthritis	6.79e-05	0.000125	CcSEcCtD
Epirubicin—Dermatitis—Prednisone—rheumatoid arthritis	6.78e-05	0.000125	CcSEcCtD
Epirubicin—Headache—Prednisone—rheumatoid arthritis	6.74e-05	0.000124	CcSEcCtD
Epirubicin—Hypersensitivity—Methotrexate—rheumatoid arthritis	6.63e-05	0.000122	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—RASGRP1—rheumatoid arthritis	6.62e-05	0.000269	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ACP5—rheumatoid arthritis	6.61e-05	0.000269	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—B3GNT2—rheumatoid arthritis	6.61e-05	0.000269	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SLC11A1—rheumatoid arthritis	6.49e-05	0.000264	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PRKCQ—rheumatoid arthritis	6.47e-05	0.000263	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—TP53—rheumatoid arthritis	6.46e-05	0.000263	CbGpPWpGaD
Epirubicin—Asthenia—Methotrexate—rheumatoid arthritis	6.45e-05	0.000119	CcSEcCtD
Epirubicin—ABCC1—Disease—NFATC1—rheumatoid arthritis	6.43e-05	0.000262	CbGpPWpGaD
Epirubicin—Nausea—Prednisone—rheumatoid arthritis	6.39e-05	0.000118	CcSEcCtD
Epirubicin—Pruritus—Methotrexate—rheumatoid arthritis	6.36e-05	0.000117	CcSEcCtD
Epirubicin—DHCR7—Metabolism—PTGS2—rheumatoid arthritis	6.33e-05	0.000257	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL10—rheumatoid arthritis	6.27e-05	0.000255	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TLE3—rheumatoid arthritis	6.23e-05	0.000253	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IRAK1—rheumatoid arthritis	6.23e-05	0.000253	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CX3CR1—rheumatoid arthritis	6.17e-05	0.000251	CbGpPWpGaD
Epirubicin—Diarrhoea—Methotrexate—rheumatoid arthritis	6.15e-05	0.000113	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—ALB—rheumatoid arthritis	6.04e-05	0.000245	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	6.03e-05	0.000245	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NCF2—rheumatoid arthritis	5.98e-05	0.000243	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—BGN—rheumatoid arthritis	5.95e-05	0.000242	CbGpPWpGaD
Epirubicin—Dizziness—Methotrexate—rheumatoid arthritis	5.95e-05	0.00011	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—IL2RB—rheumatoid arthritis	5.94e-05	0.000241	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—NOS3—rheumatoid arthritis	5.78e-05	0.000235	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—C5—rheumatoid arthritis	5.73e-05	0.000233	CbGpPWpGaD
Epirubicin—Vomiting—Methotrexate—rheumatoid arthritis	5.72e-05	0.000105	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—MMP3—rheumatoid arthritis	5.72e-05	0.000232	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ENO1—rheumatoid arthritis	5.7e-05	0.000232	CbGpPWpGaD
Epirubicin—Rash—Methotrexate—rheumatoid arthritis	5.67e-05	0.000104	CcSEcCtD
Epirubicin—Dermatitis—Methotrexate—rheumatoid arthritis	5.67e-05	0.000104	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—NFATC1—rheumatoid arthritis	5.64e-05	0.000229	CbGpPWpGaD
Epirubicin—Headache—Methotrexate—rheumatoid arthritis	5.64e-05	0.000104	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—ENO1—rheumatoid arthritis	5.59e-05	0.000227	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SAA1—rheumatoid arthritis	5.5e-05	0.000224	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	5.5e-05	0.000223	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALOX5—rheumatoid arthritis	5.48e-05	0.000223	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL5—rheumatoid arthritis	5.4e-05	0.000219	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR6—rheumatoid arthritis	5.39e-05	0.000219	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NCF1—rheumatoid arthritis	5.39e-05	0.000219	CbGpPWpGaD
Epirubicin—Nausea—Methotrexate—rheumatoid arthritis	5.34e-05	9.84e-05	CcSEcCtD
Epirubicin—ABCC1—Disease—ENO1—rheumatoid arthritis	5.33e-05	0.000217	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CSF2—rheumatoid arthritis	5.32e-05	0.000216	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NCF2—rheumatoid arthritis	5.24e-05	0.000213	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD28—rheumatoid arthritis	5.18e-05	0.000211	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SH2B3—rheumatoid arthritis	5.11e-05	0.000208	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TRAF6—rheumatoid arthritis	5.11e-05	0.000208	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GZMB—rheumatoid arthritis	5.08e-05	0.000206	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL3—rheumatoid arthritis	4.93e-05	0.0002	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL2—rheumatoid arthritis	4.93e-05	0.0002	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—rheumatoid arthritis	4.9e-05	0.000199	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IL2—rheumatoid arthritis	4.9e-05	0.000199	CbGpPWpGaD
Epirubicin—ABCC1—Disease—UBE2D1—rheumatoid arthritis	4.88e-05	0.000198	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCR5—rheumatoid arthritis	4.86e-05	0.000198	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SAA1—rheumatoid arthritis	4.82e-05	0.000196	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	4.82e-05	0.000196	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	4.81e-05	0.000195	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2RA—rheumatoid arthritis	4.79e-05	0.000195	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—C3—rheumatoid arthritis	4.75e-05	0.000193	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ADRBK1—rheumatoid arthritis	4.73e-05	0.000192	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NCF1—rheumatoid arthritis	4.72e-05	0.000192	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CD28—rheumatoid arthritis	4.54e-05	0.000185	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ENO1—rheumatoid arthritis	4.47e-05	0.000181	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	4.39e-05	0.000178	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PRKCQ—rheumatoid arthritis	4.36e-05	0.000177	CbGpPWpGaD
Epirubicin—ABCC1—Disease—STAT1—rheumatoid arthritis	4.29e-05	0.000174	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—UBE2D1—rheumatoid arthritis	4.27e-05	0.000174	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—BDKRB2—rheumatoid arthritis	4.19e-05	0.00017	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL12—rheumatoid arthritis	4.19e-05	0.00017	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	4.18e-05	0.00017	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—VEGFA—rheumatoid arthritis	4.16e-05	0.000169	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6ST—rheumatoid arthritis	4.16e-05	0.000169	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADRBK1—rheumatoid arthritis	4.14e-05	0.000168	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CAT—rheumatoid arthritis	4.1e-05	0.000167	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CAT—rheumatoid arthritis	4.02e-05	0.000163	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RASGRP1—rheumatoid arthritis	3.91e-05	0.000159	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SYK—rheumatoid arthritis	3.9e-05	0.000158	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	3.84e-05	0.000156	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PRKCQ—rheumatoid arthritis	3.82e-05	0.000155	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TGFB1—rheumatoid arthritis	3.82e-05	0.000155	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—POMC—rheumatoid arthritis	3.8e-05	0.000154	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—STAT1—rheumatoid arthritis	3.76e-05	0.000153	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL2—rheumatoid arthritis	3.72e-05	0.000151	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6R—rheumatoid arthritis	3.71e-05	0.000151	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL10—rheumatoid arthritis	3.7e-05	0.000151	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TP53—rheumatoid arthritis	3.42e-05	0.000139	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—MTHFR—rheumatoid arthritis	3.42e-05	0.000139	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP3—rheumatoid arthritis	3.38e-05	0.000137	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—TYK2—rheumatoid arthritis	3.38e-05	0.000137	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—MTHFR—rheumatoid arthritis	3.36e-05	0.000136	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CCR5—rheumatoid arthritis	3.28e-05	0.000133	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTK2—rheumatoid arthritis	3.25e-05	0.000132	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CAT—rheumatoid arthritis	3.21e-05	0.000131	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MTHFR—rheumatoid arthritis	3.2e-05	0.00013	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HLA-A—rheumatoid arthritis	3.19e-05	0.00013	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL5—rheumatoid arthritis	3.19e-05	0.00013	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TP53—rheumatoid arthritis	3.14e-05	0.000128	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CSF2—rheumatoid arthritis	3.14e-05	0.000128	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SPP1—rheumatoid arthritis	2.95e-05	0.00012	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.94e-05	0.000119	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCR5—rheumatoid arthritis	2.87e-05	0.000117	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL2RA—rheumatoid arthritis	2.83e-05	0.000115	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL2—rheumatoid arthritis	2.81e-05	0.000114	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—C3—rheumatoid arthritis	2.81e-05	0.000114	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6ST—rheumatoid arthritis	2.8e-05	0.000114	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS2—rheumatoid arthritis	2.78e-05	0.000113	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—POMC—rheumatoid arthritis	2.74e-05	0.000111	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD80—rheumatoid arthritis	2.7e-05	0.00011	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—POMC—rheumatoid arthritis	2.69e-05	0.000109	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—MTHFR—rheumatoid arthritis	2.68e-05	0.000109	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LEP—rheumatoid arthritis	2.61e-05	0.000106	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6R—rheumatoid arthritis	2.5e-05	0.000102	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALB—rheumatoid arthritis	2.5e-05	0.000101	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FN1—rheumatoid arthritis	2.46e-05	0.0001	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6ST—rheumatoid arthritis	2.45e-05	9.98e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALB—rheumatoid arthritis	2.45e-05	9.95e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NOS3—rheumatoid arthritis	2.39e-05	9.7e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CD80—rheumatoid arthritis	2.36e-05	9.6e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NOS3—rheumatoid arthritis	2.34e-05	9.52e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TYK2—rheumatoid arthritis	2.28e-05	9.25e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—POMC—rheumatoid arthritis	2.25e-05	9.12e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS3—rheumatoid arthritis	2.23e-05	9.08e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL2—rheumatoid arthritis	2.2e-05	8.93e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6R—rheumatoid arthritis	2.19e-05	8.9e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS2—rheumatoid arthritis	2.18e-05	8.88e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—POMC—rheumatoid arthritis	2.15e-05	8.72e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS2—rheumatoid arthritis	2.14e-05	8.7e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CD4—rheumatoid arthritis	2.06e-05	8.37e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTGS2—rheumatoid arthritis	2.04e-05	8.3e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TYK2—rheumatoid arthritis	1.99e-05	8.11e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOS3—rheumatoid arthritis	1.96e-05	7.96e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALB—rheumatoid arthritis	1.96e-05	7.95e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NOS3—rheumatoid arthritis	1.87e-05	7.6e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.74e-05	7.06e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS2—rheumatoid arthritis	1.71e-05	6.95e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL2—rheumatoid arthritis	1.66e-05	6.75e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6—rheumatoid arthritis	1.65e-05	6.71e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP9—rheumatoid arthritis	1.57e-05	6.38e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NFKB1—rheumatoid arthritis	1.55e-05	6.32e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAPK8—rheumatoid arthritis	1.53e-05	6.21e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TGFB1—rheumatoid arthritis	1.48e-05	6e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VEGFA—rheumatoid arthritis	1.41e-05	5.73e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TGFB1—rheumatoid arthritis	1.29e-05	5.26e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6—rheumatoid arthritis	1.11e-05	4.52e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—rheumatoid arthritis	1.07e-05	4.33e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6—rheumatoid arthritis	9.76e-06	3.96e-05	CbGpPWpGaD
